Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Humacyte, Inc. - Common Stock (NQ:HUMA)

1.680 +0.130 (+8.39%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Humacyte, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Tommy Tuberville Trades Raise Eyebrows Again: Senator Sells Put Options, Buys Small Biotech Linked To Ukraine-Russia War
Tommy Tuberville is one of the most active traders as a member of Congress. Here's a look at what he recently bought and sold. 
Via Benzinga
HUMA Stock Earnings: Humacyte Meets EPS for Q4 2023
HUMA stock results show that Humacyte met analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Earnings Scheduled For March 22, 2024
Companies Reporting Before The Bell • Agile Therapeutics (NASDAQ:AGRX) is likely to report quarterly loss at $0.54 per share on revenue of $9.20 million. 
Via Benzinga
Investor Optimism Improves Slightly; Dow Jumps Over 250 Points
The CNN Money Fear and Greed index showed a slight increase in the overall market sentiment on Thursday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Earnings Preview: Humacyte
Via Benzinga
Why Humacyte (HUMA) Shares Are Falling
Humacyte shares are trading lower by 29.2% during Friday's session. The company announced pricing of a $40.2 million public offering of common stock. 
Via Benzinga
Humacyte: Q3 Earnings Insights
Via Benzinga
Humacyte's Earnings: A Preview
Via Benzinga
Senator Tommy Tuberville's Latest 2 Stock Trades Attract The Wrong Kind Of Attention: 'Should This Be Allowed?'
Stock trades made by Senator Tommy Tuberville are drawing scrutiny on social media with potential conflicts of interest. 
Via Benzinga
Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why NetApp Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Shares of NetApp, Inc. (NASDAQ: NTAP) shares rose sharply in today’s pre-market trading after the company reported better-than-expected third-quarter financial results and issued guidance. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Pre-market stock movers are worth checking on Friday as investors prepare for the last day of trading this week with all of the latest news! 
Via InvestorPlace
Hewlett Packard Enterprise Posts Mixed Q1 Results, Joins Fisker, Plug Power And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures were lower this morning, with the Dow futures trading lower by around 100 points on Friday. 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Get Rich Quick With These 3 Penny Stocks to Buy Now
Our economy has and will continue to show strength and resilience, you should invest in these three penny stocks to buy quick. 
Via InvestorPlace
Topics Economy
Exposures Economy
Why Is Clinical-Stage Biotechnology Platform Company Humacyte Stock Gaining Friday?
Humacyte's shares surge as FDA grants Priority Review to its BLA for Human Acellular Vessel (HAV) used in urgent arterial repair. 
Via Benzinga
Exposures Product Safety
Boeing Posts Upbeat Results, Joins Stryker, Automatic Data Processing And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded mostly lower, with the Nasdaq Composite falling over 200 points on Wednesday. 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
10 Best Stock Traders In Congress In 2023 (Spoiler: Nancy Pelosi Is Back On The List)
A new report highlights the 10 members of Congress who profited the most from the stock market in 2023. 
Via Benzinga
Tommy Tuberville Lost On Tesla Trade, Could Win Big On US Steel Trade: A Look At The Congress Trades Raising Eyebrows
Senator Tommy Tuberville has been actively trading United State Steel stock and options ahead of a proposed buyout. 
Via Benzinga
Humacyte to Present at the Piper Sandler 35th Annual Healthcare Conference
From Humacyte, Inc
Via GlobeNewswire
Humacyte Announces Two Presentations at the VEITHsymposium® of Positive Clinical Results of the Human Acellular Vessel™ (HAV™) in the Treatment of Vascular Trauma
From Humacyte, Inc
Via GlobeNewswire
Sidoti Events, LLC’s Virtual November Micro-Cap Conference
Via ACCESSWIRE
Humacyte Third Quarter 2023 Financial Results and Business Update
From Humacyte, Inc
Via GlobeNewswire
Humacyte to Present Third Quarter Financial Results and Provide Corporate Update on November 9, 2023
From Humacyte, Inc
Via GlobeNewswire
Humacyte Publishes Preclinical Results Showing Human Acellular Vessel™ (HAV™) Patency as Modified Blalock–Taussig–Thomas Shunt in Juvenile Primate Model
-Outcomes exhibit potential of HAV for palliative treatment of congenital heart disease- 
From Humacyte, Inc
Via GlobeNewswire
Humacyte to Present at the Cantor Global Healthcare Conference
From Humacyte, Inc
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback